1. Calkins H, Reynolds MR, Spector P, et al. Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation. Two Systematic Literature Reviews and MetaAnalyses. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):349-61. doi:10.1161/CIRCEP.108.824789.
2. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circulation: Arrhythmia and Electrophysiology. 2014;7(1):31-8. doi:10.1161/CIRCEP.113.000806.
3. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637-44. doi:10.1161/CIRCULATIONAHA.115.019406.
4. Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417-27. doi:10.1056/NEJMoa1707855.
5. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized ClinicalTrial. JAMA. 2019;321(13):1261-74. doi:10.1001/jama.2019.0693.
6. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi:10.1016/j.jacc.2012.11.064.
7. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374:2235-45. doi:10.1056/NEJMoa1602014.
8. Houmsse M, Daoud EG. Radiation exposure: a silent complication of catheter ablation procedures. Heart Rhythm. 2012;9(5):715-6. doi:10.1016/j.hrthm.2012.01.015.
9. Heidbuchel H, Wittkampf FH, Van E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014;16(7):946-64. doi:10.1093/europace/eut409.
10. De Ponti R. Reduction of radiation exposure in catheter ablation of atrial fibrillation: Lesson learned. World J Cardiol. 2015;7(8):442-8. doi:10.4330/wjc.v7.i8.442.
11. Miller DL, Klein LW, Balter S, et al. Special communication — occupational health hazards in the interventional laboratory: progress report of the multispecialty occupational health group. J Am Coll Radiol. 2010;7(9):679-83. doi:10.1016/j.jacr.2010.07.010.
12. Ferguson JD, Helms A, Mangrum JM, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circulation: Arrhythmia and Electrophysiology. 2009;2(6):611-9. doi:10.1161/CIRCEP.109.872093.
13. Reddy VY, Morales G, Ahmed H, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11):1644-53. doi:10.1016/j.hrthm.2010.07.011.
14. Da Costa A, Ben H’dech M, Romeyer-Bouchard C, et al. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: A single-centre prospective study. Archives of Cardiovascular Diseases. 2013;106(8-9):423-32. doi:10.1016/j.acvd.2013.04.008.
15. Percell RL, Sharpe E, Percell JE. SANS FLUORO (SAy No Series to FLUOROscopy): A First-Year Experience. Journal of the American College of Cardiology. 2016;7(11):2529-2534. doi:10.19102/icrm.2016.071102.
16. Sommer P, Bertagnolli L, Kircher S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. EP Europace. 2018;20(12):1952-8. doi:10.1093/europace/eux378.
17. Cacciotti L, Passaseo I. Management of Atrial Fibrillation in Pregnancy. J Atr Fibrillation. 2010;3(3):295. doi:10.4022/jafib.295.
18. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); Regitz-Zagrosek V. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147-97. doi:10.1093/eurheartj/ehr218.
19. Bongiorni MG, Di Cori A, Soldati E, et al. Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy. Europace. 2008;10(8):1018-21. doi:10.1093/europace/eun120.
20. Szumowski L, Szufladowicz E, Orczykowski M, et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol. 2010;21(8):877-82. doi:10.1111/j.1540-8167.2010.01727.
21. Chen G, Sun G, Xu R, et al. Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy. Two case reports and literature review. Medicine (Baltimore). 2016;95(32):e4487. doi:10.1097/MD.0000000000004487.
22. Kozluk E, Piatkowska A, Kiliszek M, et al. Catheter ablation of cardiac arrhythmias in pregnancy without fluoroscopy: A case control retrospective study. Adv Clin Exp Med. 2017;26(1):129-34. doi:10.17219/acem/68275.
23. Сапельников О. В., Партигулова А. С., Саидова М. А. и др. Роль внутрисердечной эхокардиографии в клинической электрофизиологии. Кардиология. 2015;1:64-9.